CNCR vs. GNOM ETF Comparison

Comparison of Loncar Cancer Immunotherapy ETF (CNCR) to Global X Genomics & Biotechnology ETF (GNOM)
CNCR

Loncar Cancer Immunotherapy ETF

CNCR Description

ETF Series Solutions - Loncar Cancer Immunotherapy ETF is an exchange traded fund launched by ETF Series Solutions. The fund is co-managed by Exchange Traded Concepts, LLC and Vident Investment Advisory, LLC. It invests in public equity markets of the United States. The fund invests in stocks of companies operating in the pharmaceutical or biotechnology sectors, including those companies identified as having a high strategic focus on the development of drugs that harness the body's own immune system to fight cancer. It invests in stocks of companies across all market capitalizations. The fund seeks to replicate the performance of the Loncar Cancer Immunotherapy Index, by investing in stocks of companies as per their weightings in the index. ETF Series Solutions - Loncar Cancer Immunotherapy ETF is domiciled in the United States.

Grade (RS Rating)

Last Trade

$13.86

Average Daily Volume

44,712

Number of Holdings *

71

* may have additional holdings in another (foreign) market
GNOM

Global X Genomics & Biotechnology ETF

GNOM Description The investment seeks to provide investment results that correspond generally to the price and yield performance, before fees and expenses, of the Solactive Genomics Index ("underlying index"). The fund invests at least 80% of its total assets in the securities of the underlying index. The underlying index is designed to provide exposure to exchange-listed companies that are positioned to benefit from further advances in the field of genomic science and biotechnology, as well as applications thereof (collectively, "Genomics & Biotechnology Companies"), as defined by Solactive AG, the provider of the underlying index. The fund is non-diversified.

Grade (RS Rating)

Last Trade

$9.60

Average Daily Volume

74,643

Number of Holdings *

38

* may have additional holdings in another (foreign) market
Performance
Period CNCR GNOM
30 Days -10.45% -11.96%
60 Days -12.21% -13.26%
90 Days 1.72% -9.80%
12 Months 11.43% -17.73%
6 Overlapping Holdings
Symbol Grade Weight in CNCR Weight in GNOM Overlap
ALLO F 1.05% 0.76% 0.76%
BNTX F 1.26% 3.3% 1.26%
CRBU F 1.01% 0.6% 0.6%
LEGN F 1.04% 2.77% 1.04%
LYEL C 1.45% 0.59% 0.59%
TSVT F 1.68% 0.46% 0.46%
CNCR Overweight 65 Positions Relative to GNOM
Symbol Grade Weight
GERN B 2.62%
ACRV B 2.52%
ELVN B 2.3%
JANX B 1.83%
NUVB B 1.75%
PRLD C 1.68%
RVMD B 1.48%
NRIX B 1.47%
ITOS F 1.46%
GLUE F 1.44%
ACET F 1.43%
FHTX F 1.41%
HCM A 1.4%
MGNX D 1.4%
MRK A 1.39%
STRO F 1.37%
AURA F 1.35%
RAPT F 1.35%
EXEL A 1.34%
MOR A 1.34%
SDGR F 1.32%
INBX D 1.32%
YMAB C 1.32%
GMAB F 1.3%
VOR F 1.3%
DAWN C 1.3%
CGEM B 1.3%
PGEN C 1.3%
BPMC B 1.29%
IPHA D 1.28%
ERAS F 1.28%
BCYC C 1.27%
SNDX D 1.27%
REGN C 1.25%
DCPH D 1.25%
ZNTL F 1.25%
IGMS F 1.23%
IMCR D 1.23%
BMY F 1.23%
MRUS C 1.23%
IDYA D 1.23%
XNCR F 1.22%
DNA F 1.19%
RCUS F 1.18%
KYMR C 1.16%
KPTI F 1.15%
KURA C 1.15%
IMTX F 1.15%
SWTX C 1.14%
AUTL F 1.14%
TYRA C 1.11%
RLAY F 1.11%
IOVA D 1.11%
ACLX D 1.09%
REPL F 1.07%
FATE D 1.04%
NUVL C 1.03%
ARVN D 1.03%
SMMT D 1.02%
MRSN D 1.01%
BMEA F 0.99%
RXRX F 0.96%
IMRX F 0.88%
RPTX F 0.88%
GNLX F 0.81%
CNCR Underweight 32 Positions Relative to GNOM
Symbol Grade Weight
NTRA A -8.2%
CRSP F -5.16%
MRNA A -4.9%
RARE D -4.89%
A C -4.74%
BMRN A -4.02%
SRPT C -3.99%
ILMN D -3.77%
QGEN D -3.76%
TECH F -3.73%
RCKT D -3.59%
RNA A -3.41%
ARWR F -3.41%
ALNY F -3.31%
BEAM F -3.3%
NTLA F -3.21%
MYGN F -2.99%
TXG F -2.86%
VCYT D -2.76%
VRTX C -1.97%
SANA C -1.66%
GILD F -1.55%
VIR F -1.46%
RGNX F -1.38%
EDIT F -0.92%
CDNA F -0.87%
FLGT F -0.78%
PACB F -0.69%
VERV F -0.59%
QURE F -0.4%
PSTX F -0.27%
BLUE F -0.2%
Compare ETFs